HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giorgio Scalise Selected Research

antimicrobial peptide IB-367 (iseganan)

11/2007Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.
1/2006In vitro activity of synthetic antimicrobial peptides against Candida.
11/2003Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giorgio Scalise Research Topics

Disease

35Infections
04/2009 - 09/2002
22Sepsis (Septicemia)
04/2009 - 07/2002
14Septic Shock (Toxic Shock Syndrome)
10/2008 - 01/2002
11Staphylococcal Infections
09/2008 - 10/2003
7Body Weight (Weight, Body)
09/2009 - 01/2002
7Bacteremia
11/2007 - 02/2005
3Pseudomonas Infections
12/2008 - 12/2007
3Wounds and Injuries (Trauma)
06/2008 - 01/2008
3Peritonitis
01/2008 - 11/2002
3Catheter-Related Infections
09/2006 - 10/2005
2Obstructive Jaundice (Cholestatic Jaundice)
11/2006 - 09/2006
2Shock
02/2005 - 02/2004
2Candidiasis (Moniliasis)
11/2004 - 12/2002
2Necrosis
09/2004 - 01/2002
1Aspergillosis
09/2009
1Gram-Negative Bacterial Infections
12/2008
1Neutropenia
10/2008
1Infertility (Sterility)
07/2008
1Surgical Wound
04/2008
1Intraabdominal Infections
01/2008
1Wound Infection (Wound Infections)
01/2008
1Systemic candidiasis
03/2007
1Zygomycosis (Phycomycosis)
01/2007
1Endotoxemia
09/2006
1Fungemia
07/2006
1Candidemia
07/2006

Drug/Important Bio-Agent (IBA)

21Anti-Bacterial Agents (Antibiotics)IBA
09/2008 - 02/2003
12Peptides (Polypeptides)IBA
09/2008 - 01/2002
10EndotoxinsIBA
11/2006 - 01/2002
8Antimicrobial PeptidesIBA
12/2008 - 12/2004
8RNAIII inhibiting peptideIBA
06/2008 - 08/2003
8temporinIBA
04/2008 - 11/2002
7VancomycinFDA LinkGeneric
07/2008 - 10/2003
6LipopolysaccharidesIBA
01/2008 - 06/2003
6GlycopeptidesIBA
04/2007 - 09/2002
6CathelicidinsIBA
09/2006 - 01/2004
6ImipenemFDA Link
07/2006 - 07/2002
5Amphotericin B (Amphotericin)FDA LinkGeneric
09/2009 - 02/2003
5Pharmaceutical PreparationsIBA
05/2008 - 07/2004
5Linezolid (Zyvox)FDA Link
11/2007 - 10/2003
5Polyethylene Terephthalates (Polyethylene Terephthalate)IBA
06/2007 - 09/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2006 - 01/2002
4Rifampin (Rifampicin)FDA LinkGeneric
04/2009 - 06/2006
4SolutionsIBA
07/2008 - 01/2002
4BMAP-28IBA
07/2008 - 12/2004
4PiperacillinFDA LinkGeneric
07/2006 - 01/2002
4pexigananIBA
01/2006 - 09/2004
4MagaininsIBA
11/2005 - 01/2002
3Tachypleus tridentatus tachyplesin peptideIBA
12/2008 - 12/2007
3TeicoplaninIBA
06/2008 - 12/2007
3Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
01/2008 - 12/2007
3antimicrobial peptide IB-367 (iseganan)IBA
11/2007 - 11/2003
3posaconazoleFDA Link
01/2007 - 02/2003
3Fluconazole (Zonal)FDA LinkGeneric
10/2004 - 12/2002
3Sodium ChlorideFDA LinkGeneric
07/2004 - 01/2002
2buforin IIIBA
04/2009 - 07/2002
2Clarithromycin (Biaxin)FDA LinkGeneric
12/2008 - 11/2005
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2008 - 01/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2008 - 01/2008
2distinctinIBA
09/2008 - 04/2007
2indolicidinIBA
01/2008 - 07/2002
2Colistin (Coly-Mycin)FDA Link
07/2007 - 11/2005
2LipopeptidesIBA
06/2007 - 01/2007
2AgarIBA
06/2007 - 08/2003
2ExotoxinsIBA
09/2006 - 02/2005
2Proteins (Proteins, Gene)FDA Link
05/2006 - 08/2003
2Caspofungin (Cancidas)FDA Link
12/2005 - 10/2004
2Ciprofloxacin (Cipro)FDA LinkGeneric
11/2005 - 10/2005
2Anti-Infective Agents (Microbicides)IBA
11/2005 - 12/2004
2AmidesIBA
11/2005 - 01/2002
2quinupristin-dalfopristin (Synercid)FDA Link
10/2005 - 09/2002
2HistatinsIBA
03/2005 - 07/2004
2Polymyxin B (Aerosporin)FDA LinkGeneric
07/2004 - 01/2002
2Levofloxacin (Levaquin)FDA Link
10/2003 - 01/2002
1AnidulafunginFDA Link
09/2009
1Paromomycin (Paromomycin Sulfate)FDA LinkGeneric
11/2008
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
10/2008
1antineoplaston A10 (A 10)IBA
07/2008
1allevynIBA
06/2008
1hamamelitanninIBA
05/2008
1Polymethyl Methacrylate (Sol)IBA
07/2007
1lysyllysine (Lys-Lys)IBA
06/2007
1Pal-Lys-Lys-NH2IBA
06/2007
1BMAP-27IBA
11/2006
1tritrpticinIBA
08/2006
1Ertapenem (Invanz)FDA Link
08/2006
1Minocycline (Cyclops)FDA LinkGeneric
06/2006
1Uperoleia mjobergii uperin 3.6 peptideIBA
01/2006

Therapy/Procedure

11Punctures
01/2008 - 07/2002
11Ligation
01/2008 - 07/2002
10Intraperitoneal Injections
10/2008 - 01/2002
7Therapeutics
09/2009 - 12/2002
7Central Venous Catheters
11/2007 - 10/2005
3Stents
07/2008 - 12/2007
3Prostheses and Implants (Prosthesis)
06/2007 - 08/2003
2Antibiotic Prophylaxis
07/2008 - 06/2006
2Intravenous Injections
11/2004 - 09/2004
1Operative Surgical Procedures
07/2008
1Drug Therapy (Chemotherapy)
01/2008
1Catheters
07/2006